Novel oral anti-influenza drug candidate AV5080 | Zendy

Alexandre V. Ivachtchenko | Zendy; Yan A. Ivanenkov | Zendy; Oleg D. Mitkin | Zendy; Pavel Yamanushkin | Zendy; V. Bichko | Zendy; Natalia A. Shevkun | Zendy; Ruben N. Karapetian | Zendy; Irina A. Leneva | Zendy; О. В. Борисова | Zendy; Mark S. Veselov | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Novel oral anti-influenza drug candidate AV5080

Author(s) -

Alexandre V. Ivachtchenko,

Yan A. Ivanenkov,

Oleg D. Mitkin,

Pavel Yamanushkin,

V. Bichko,

Natalia A. Shevkun,

Ruben N. Karapetian,

Irina A. Leneva,

О. В. Борисова,

Mark S. Veselov

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku074

Subject(s) - oseltamivir , neuraminidase , neuraminidase inhibitor , potency , drug candidate , virology , drug , influenza a virus , human influenza , virus , drug resistance , medicine , microbiology and biotechnology , pharmacology , biology , covid-19 , in vitro , infectious disease (medical specialty) , biochemistry , disease

Development of a novel drug candidate with improved potency against influenza virus neuraminidase compared with currently available therapeutics, and high activity against oseltamivir-resistant viruses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research